Latest Press Releases
- 05/16/2013 TESARO Announces Presentation of Niraparib Clinical Data at the 2013 ASCO Annual Meeting
- 05/09/2013 TESARO Announces Election of Dr. James Armitage to Board of Directors and Results of Annual Stockholder Meeting
- 04/25/2013 Tesaro Announces First-Quarter 2013 Operating Results
- 04/18/2013 TESARO to Announce First Quarter 2013 Financial Results on April 25, 2013
Who We Are
We are a team of associates who strive to be responsive to the needs of cancer patients. From this grows our determination to offer better health and more hope for those who live with cancer. Read More →
TESARO is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients by developing and commercializing safer and more effective therapeutics. TESARO is headquartered in Waltham, Massachusetts.